Hazards of prolonged low-dose methotrexate therapy.
D000328:Adult; D000741:Anemia, Aplastic / Q000139:chemically induced*; D001772:Blood Cell Count; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D006529:Hepatomegaly / Q000139:chemically induced; D006801:Humans; D002955:Leucovorin / Q000627:therapeutic use; D008099:Liver / Q000187:drug effects; D008111:Liver Function Tests; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D011565:Psoriasis / Q000188:drug therapy; D013163:Splenomegaly / Q000139:chemically induced; D013997:Time Factors
D002955:Leucovorin; D008727:Methotrexate